Acquisition of Sanitas, Lithuania's Largest Pharmaceuticals Manufacturer

01.01.2012 Acquisition of Sanitas, Lithuania's Largest Pharmaceuticals Manufacturer

TGS Baltic advised and provided full transaction services to Valeant Pharmaceuticals International, Inc. on the acquisition of 87.2% of the shares in AB Sanitas that were listed on the Nasdaq OMX Vilnius exchange for a total price of 365 million euros.

The acquisition was followed by a successfully mandatory tender offer and squeeze-out resulting in 100% ownership and delisting of the company. We advised the buyer at all stages of the acquisition, which was the biggest in Lithuania since 2007 and one of the biggest in the Baltics at the time.

Valeant Pharmaceuticals is a multinational specialty pharmaceutical company headquartered in Montreal, Quebec. It has approximately 7,000 employees worldwide and is listed on both the New York Stock Exchange and the Toronto Stock Exchange.